20/20 HealthCare Partners LLC — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
EnClear Therapiesencleartherapies.cominFeb 2024
EnClear Therapies is a bio/med-tech company developing the EnTrega CSF platform, focused on cerebrospinal fluid-related therapies.
BiotechDigital HealthHealthtechMedical DevicesCambridge, US
Anthony DePasqua(Executive Officer, Director)inJason Camm(Director)Kasper Roet(Director)Tony DePasqua(President & CEO)Kevin Kalish(COO)Marcie Glicksman(VP Biology)
PartnerHillel Bachrach· led
Co-investorsFlucas VenturesTachyon VenturesVU Venture PartnersDolby Family Ventures
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.